全文获取类型
收费全文 | 8217篇 |
免费 | 358篇 |
国内免费 | 67篇 |
专业分类
耳鼻咽喉 | 188篇 |
儿科学 | 249篇 |
妇产科学 | 106篇 |
基础医学 | 1361篇 |
口腔科学 | 131篇 |
临床医学 | 414篇 |
内科学 | 1982篇 |
皮肤病学 | 168篇 |
神经病学 | 592篇 |
特种医学 | 284篇 |
外科学 | 1340篇 |
综合类 | 22篇 |
预防医学 | 141篇 |
眼科学 | 107篇 |
药学 | 486篇 |
中国医学 | 24篇 |
肿瘤学 | 1047篇 |
出版年
2023年 | 36篇 |
2022年 | 75篇 |
2021年 | 200篇 |
2020年 | 95篇 |
2019年 | 122篇 |
2018年 | 155篇 |
2017年 | 139篇 |
2016年 | 161篇 |
2015年 | 161篇 |
2014年 | 234篇 |
2013年 | 292篇 |
2012年 | 478篇 |
2011年 | 573篇 |
2010年 | 328篇 |
2009年 | 247篇 |
2008年 | 425篇 |
2007年 | 499篇 |
2006年 | 506篇 |
2005年 | 537篇 |
2004年 | 567篇 |
2003年 | 527篇 |
2002年 | 605篇 |
2001年 | 114篇 |
2000年 | 68篇 |
1999年 | 109篇 |
1998年 | 136篇 |
1997年 | 137篇 |
1996年 | 113篇 |
1995年 | 82篇 |
1994年 | 100篇 |
1993年 | 105篇 |
1992年 | 71篇 |
1991年 | 74篇 |
1990年 | 59篇 |
1989年 | 51篇 |
1988年 | 48篇 |
1987年 | 42篇 |
1986年 | 45篇 |
1985年 | 36篇 |
1984年 | 39篇 |
1983年 | 24篇 |
1982年 | 34篇 |
1981年 | 25篇 |
1980年 | 30篇 |
1979年 | 14篇 |
1978年 | 24篇 |
1977年 | 11篇 |
1976年 | 17篇 |
1974年 | 8篇 |
1973年 | 11篇 |
排序方式: 共有8642条查询结果,搜索用时 31 毫秒
181.
Toshio Kinoshita Hitomi Yuzawa Kazuhiko Natori Ryo Wada Shintaro Yao Kensuke Yano Katsuya Akitsu Hideki Koike Masaya Shinohara Tadashi Fujino Hideaki Shimada Takanori Ikeda 《Journal of cardiology》2021,77(4):388-394
BackgroundDealing with chemotherapy-related cardiac dysfunction (CTRCD) remains a significant problem complicated by the difficulty in early detection of cardiotoxicity. Electrocardiogram (ECG) is expected to be the most realistic methodology due to lower cost-performance and non-invasiveness. We investigated the long-term visual fluctuations in the ECG waveforms in patients with chronic doxorubicin (DOX)-induced cardiotoxicity to identify ECG indices for the early detection of cardiotoxicity.MethodsWe conducted a retrospective case series study by reviewing the medical records of 470 consecutive patients with malignant lymphoma who were treated with DOX at our institute between January 2010 and December 2017. Of them, 23 (4.9%) patients developed left ventricular dysfunction and were diagnosed with CTRCD using echocardiography. We assessed the ECG indices on 12-lead ECG recordings before and after treatment in 15 patients; eight patients were excluded due to conduction disturbances or atrial fibrillation.ResultsCTRCD was detected at a median of 475 (interquartile range, IQR: 341–1333) days after initiating chemotherapy. The evaluation of ECG indices preceding CTRCD development was performed 93 (IQR: 52–232) days before the detection of CTRCD. In the stage of CTRCD, the most significant ECG change was T-wave flattening in leads V3–V6 (12 patients, 80%). Additionally, QTa prolongation was observed in leads I and aVL (n = 10, 66%), leads II, III, and aVF (n = 9, 60%), and leads V3–V6 (n = 10, 73%). These ECG changes were not observed before the treatment but were detected mildly in the pre-CTRCD stage, which subsequently worsened in the CTRCD stage.ConclusionsThis study indicated that T-wave changes and QTa prolongation may be useful as an early indicator before the onset of CTRCD in patients with DOX-induced cardiotoxicity. 相似文献
182.
Katayama T Nakashima H Takagi C Honda Y Suzuki S Iwasaki Y Yamamoto T Yoshioka M Yano K 《International heart journal》2005,46(5):771-781
The aim of the present study was to investigate the prognostic significance of time-delay to peak creatine kinase (CK) after successful direct percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI). Our 240 consecutive first AMI attack subjects admitted within 5 hours from onset were successfully reperfused by direct PCI therapy. Subjects were divided into two groups according to the upper quartile value of peak-CK time from onset, the early peak-CK group (peak-CK time < or = 16 hours from onset, n = 180) and the late peak-CK group (peak-CK time > 16 hours, n = 60). (I) The early ST-segment resolution rate was lower in the late peak-CK group compared with the early peak-CK group (P < 0.05), and there were significantly fewer patients with preinfarction angina pectoris in the late peak-CK group than in the early peak-CK group (P < 0.01). (II) LVEF in the chronic stage was significantly lower in the late peak-CK group than in the early peak-CK group (49 +/- 13% versus 57 +/- 13%, P < 0.001). (III) There were significantly more patients with major complications in the late peak-CK group than in the early peak-CK group (required CABG: 10% versus 3%, P < 0.05; cardiac death: 18% versus 3%, P = 0.0001). (IV) Multivariate analysis identified late peak-CK as an independent predictor of cardiac death (Odds ratio 7.91, 95% C.I. 1.40-44.11, P < 0.05). In patients with AMI, the time-delay to peak-CK after successful direct PCI may be closely related to left-ventricular systolic dysfunction and poor patient outcome, including mortality. 相似文献
183.
Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection 总被引:20,自引:0,他引:20
Hwang IR Kodama T Kikuchi S Sakai K Peterson LE Graham DY Yamaoka Y 《Gastroenterology》2002,123(6):1793-1803
BACKGROUND & AIMS: Although epidemiological studies suggest that interleukin (IL)-1 genetic polymorphisms are involved in Helicobacter pylori-related gastric carcinogenesis, the data are conflicting regarding the effects of these polymorphisms on IL-1beta production. METHODS: IL-1B-511 polymorphism was genotyped by polymerase chain reaction (PCR)-restriction fragment length polymorphism, and IL-1RN variable number of tandem repeats was determined by PCR. Mucosal IL-1beta levels were measured by enzyme-linked immunosorbent assay. To determine which factors influence mucosal IL-1beta levels, gastric inflammation, and atrophy, multiple regression analyses were performed. RESULTS: We studied 117 H. pylori-infected Japanese patients. Carriers of the IL-1B-511T/T genotype or IL-1RN*2 allele had higher mucosal IL-1beta levels than noncarriers (partial regression coefficient [PRC] +/- SE), TT versus CC: 37.6 +/- 6 [antrum] and 32.1 +/- 6 [corpus] pg/mg protein (P < 0.001 for each), *1/*2 versus *1/*1: 24 +/- 8 [antrum] (P <0.01) and 36.5 +/- 7 [corpus] (P <0.001). Simultaneous carriers of IL-1B-511T/T genotype and IL-1RN*2 allele had the highest IL-1beta levels (82.9 +/- 12 [antrum] and 87.2 +/- 11 [corpus]) and showed a synergistic effect between 2 loci. The *1/*2 carriers were closely related to atrophy (PRC +/- SE; 0.87 +/- 0.4 [antrum] and 0.93 +/- 0.4 [corpus], P < 0.05), whereas being a carrier of the -511T/T genotype was related to severe gastric inflammation. CONCLUSIONS: IL-1 genetic polymorphisms influenced H. pylori-related gastric mucosal IL-1beta levels and were related to gastric inflammation and atrophy, factors thought to be important in gastric carcinogenesis. 相似文献
184.
Lewis Blood Group-Related Antigen Expression in Normal Gastric Epithelium, Intestinal Metaplasia, Gastric Adenoma, and Gastric Carcinoma 总被引:6,自引:0,他引:6
Kenji Kobayashi M.D. Junichi Sakamoto M.D. Tsuyoshi Kito M.D. Yoshitaka Yamamura M.D. Takashi Koshikawa M.D. Miyuki Fujita Tadashi Watanabe M.D. Hiroaki Nakazato M.D. 《The American journal of gastroenterology》1993,88(6):919-924
The expression of blood group-related antigens of the Lewis system in normal gastric mucosa, intestinal metaplasia, gastric adenoma, and gastric carcinoma was examined. Ninety-five percent of normal foveolar epithelial samples stained positive for Lewisb antigen, whereas only 10.0% expressed Lewisa antigen. In contrast, intestinal metaplasia specimens had increased Lewisa antigen expression and slightly decreased Lewisb antigen expression. A similar pattern of Lewisa and Lewisb expression was observed in gastric adenomas and intestinal type adenocarcinomas. Lewisx and Lewisy were detected in all normal deep glands, but were not expressed in the majority of intestinal metaplasia specimens. In addition, only 20–40% of gastric adenomas and gastric carcinomas expressed Lewisx and Lewisy antigens. These changes in Lewis antigen expression in intestinal metaplasia, adenomas, and intestinal type adenocarcinomas suggest that altered expression of Lewis blood group-related antigens may correlate with cell transformation processes. 相似文献
185.
Kuwayama Kenji Miyaguchi Hajime Kanamori Tatsuyuki Tsujikawa Kenji Yamamuro Tadashi Segawa Hiroki Okada Yuki Iwata Yuko T. 《Forensic Toxicology》2022,40(2):215-233
Forensic Toxicology - Since the 1980s, the detection sensitivity of mass spectrometers has increased by improving the analysis of drugs in hair. Accordingly, the number of hair strands required for... 相似文献
186.
Tsujikawa Kenji Okada Yuki Segawa Hiroki Yamamuro Tadashi Kuwayama Kenji Kanamori Tatsuyuki Iwata Yuko T. 《Forensic Toxicology》2022,40(1):125-131
Forensic Toxicology - Various forms of cannabidiol (CBD)-containing products are sold in Japan. CBD is easily converted to mixtures of ?9-tetrahydrocannabinol (?9-THC) and its isomer,... 相似文献
187.
Molecular mechanism of vascular disease in metabolic syndrome X 总被引:1,自引:0,他引:1
188.
Shu Kasama Takuji Toyama Takashi Hatori Hiroyuki Sumino Hisao Kumakura Yoshiaki Takayama Shuichi Ichikawa Tadashi Suzuki Masahiko Kurabayashi 《Journal of the American College of Cardiology》2007,49(6):667-674
OBJECTIVES: We sought to evaluate the effects of atrial natriuretic peptide (ANP) on cardiac sympathetic nerve activity (CSNA) and left ventricular (LV) remodeling in patients with first anterior acute myocardial infarction (AMI) after primary coronary angioplasty. BACKGROUND: The activation of the renin-angiotensin-aldosterone system (RAAS) prevents the uptake of norepinephrine in the myocardium. Atrial natriuretic peptide, a circulating hormone of cardiac origin, has vasodilatory and diuretic properties, and can inhibit the RAAS. METHODS: We studied 50 patients with first anterior AMI who were randomly assigned to receive ANP (group A) or isosorbide dinitrate (group B) before and after primary coronary angioplasty. The ANP or ISDN was continuously infused >48 h. The extent score (ES) was determined from 99mTc-pyrophosphate scintigraphy to evaluate the area of initial myocardial damage 3 to 5 days after primary angioplasty. The LV end-diastolic volume (LVEDV) and LV ejection fraction (LVEF) were determined by left ventriculography 2 weeks later. The delayed heart/mediastinum count (H/M) ratio, delayed total defect score (TDS), and washout rate (WR) were determined from 123I-meta-iodobenzylguanidine scintigraphy after 3 weeks. RESULTS: After primary angioplasty, age, gender, risk factors, peak serum creatine phosphokinase concentration, recanalization time, and ES were similar in the 2 groups. However, in group A (n = 25), the TDS was significantly lower (34 +/- 8 vs. 41 +/- 8; p < 0.05), the H/M ratio was significantly higher (1.96 +/- 0.18 vs. 1.74 +/- 0.23; p < 0.05), and the WR was significantly lower (35 +/- 8% vs. 44 +/- 12%; p < 0.005) than in group B (n = 25). Moreover, the LVEDV and LVEF in group A were better than in group B (LVEDV: 85.5 +/- 28.5 ml vs. 106.3 +/- 39.4 ml [p < 0.05]; LVEF: 47.9 +/- 10.2% vs. 41.5 +/- 11.8% [p < 0.05]). CONCLUSIONS: Intravenous ANP improves CSNA and prevents LV remodeling in patients with first anterior AMI. 相似文献
189.
Okada H Takagi A Murate T Adachi T Yamamoto K Matsushita T Takamatsu J Sugita K Sugimoto M Yoshioka A Yamazaki T Saito H Kojima T 《British journal of haematology》2004,126(2):219-225
Eight distinct and potentially causative mutations were identified in eight unrelated Japanese patients with protein S (PS) deficiency, by direct DNA sequencing of the protein Salpha (PSalpha) gene-specific polymerase chain reaction products of all 15 exons and exon/intron boundaries. There were five missense mutations, including two novel mutations (Cys80Tyr and Arg314His), and three showed a major impact on the expected gene products: novel mutations of a 5-bp deletion (delCTCTG887:Cys206Stop) and a nonsense mutation (Glu208Stop), as well as a previously reported splice site (exon 10 +5 A-->G) mutation. One of the patients showed compound heterozygosity for delCTCTG887 and 732A-->G. Investigation for the cosegregation state of these two mutations with PS deficiency in the patient's family suggested that the delCTCTG887 mutation was responsible for the abnormal phenotype and that the 732A-->G (Lys155Glu) mutation did not appear to play a key role. However, we also identified the same 732A-->G (Lys155Glu) mutation in an unrelated patient with apparent PS deficiency with severe pulmonary embolism, and found that this mutation seemed to cosegregate with a PS-deficient state in her family members. These data implied that unknown factor(s) other than the 732A-->G mutation itself might influence phenotypic expression of PS status in different individuals. 相似文献
190.
Tadanori Ishikawa Tadashi Horimi Yasuo Shima Takahiro Okabayashi Yutaka Nishioka Madoka Hamada Junichi Ichikawa Atsuhito Tsuji Masahiro Takamatsu Sojiro Morita 《Journal of hepato-biliary-pancreatic sciences》2003,10(3):233-238
Background/Purpose. An aggressive approach is required to resect advanced carcinoma of the gallbladder. Therefore, an extended surgical procedure often brings about a poor surgical outcome. To test whether an aggressive surgical treatment can improve the survival rate for primary advanced carcinoma of the gallbladder, 59 patients with stage IV primary gallbladder carcinoma were studied. Methods. Patients were divided into three treatment groups for the survival analysis: group A (resectional surgery, n = 29), group B (low-dose cis-diamminedichloroplatinum-II and 5-fluorouracil therapy, n = 10), and group C (exploratory laparotomy, other treatment modalities, or no treatment, n = 20). Results. The prognosis of group A patients was significantly better than that of group B (P = 0.018) or group C (P = 0.0009). Furthermore, group A patients were divided into subgroups. The prognosis of patients resected with no distant metastasis (group A1) was significantly better than that of patients resected with distant metastases of the distant lymph nodes and the liver (group A2) (P = 0.0004). Also, there was no significant difference in the survival rate between the patients resected with distant metastasis (group A2) and chemotherapy cases (group B). Conclusions. These results indicated that radical surgery should be performed for patients with no distant metastasis, and that chemotherapy might be a useful alternative treatment for patients with distant metastasis in advanced carcinoma of the gallbladder. 相似文献